person

Marco Armando, MD, PhD

as of 2026-07-01
Monitor thisAsk about this
at a glance
Roles: Principal Investigator
Synthesized from structured facts only — each point cited above.

Profile

Affiliation
Bambino Gesù Hospital and Research Institute
Roles
Principal Investigator
Trial investigator
no

Trials led

1
Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
NCT02070211Phase 2, Phase 3Unknown

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
PRINCIPAL_INVESTIGATOR
Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
trial